FFA
ANIP icon

Farther Finance Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Farther Finance Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.81K Buy
135
+29
+27% +$2.23K ﹤0.01% 4628
2026
Q2 		$8.78K Buy
106
+6
+6% +$481 ﹤0.01% 4509
2026
Q1 		$7.6K Buy
100
+1
+1% +$78 ﹤0.01% 4283
2025
Q4 		$7.82K Buy
99
+15
+18% +$1.3K ﹤0.01% 4070
2025
Q3 		$7.69K Buy
84
+3
+4% +$245 ﹤0.01% 3557
2025
Q2 		$5.29K Hold
81
– – ﹤0.01% 3340
2025
Q1 		$5.51K Buy
+81
New +$4.84K ﹤0.01% 3011
2024
Q2 		– Sell
-3
Closed -$204 – 3820
2024
Q1 		$204 Sell
3
-2
-40% -$121 ﹤0.01% 3270
2023
Q4 		$276 Buy
+5
New +$275 ﹤0.01% 3151

Other funds holding ANIP

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Farther Finance Advisors's ANIP Position: Q3 2026 in Review

Farther Finance Advisors increased its ANI Pharmaceuticals (ANIP) stake by 27% in Q3 2026, buying an estimated $2.23K and bringing the position to 135 shares worth $9.81K. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

Farther Finance Advisors first reported a position in ANIP in Q4 2023 and has held it in 9 quarters since. 6 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Farther Finance Advisors held 135 shares of ANI Pharmaceuticals worth $9.81K as of Q3 2026.
  • Farther Finance Advisors bought 29 ANI Pharmaceuticals shares in Q3 2026, an estimated $2.23K.
  • ANI Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4628 holding.
  • Farther Finance Advisors first reported a position in ANI Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • 6 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.